Search - tctmd.com

Displaying 1 - 20 of 434

Sort: Relevancy | Date

News Conference News TCT 2025

‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains

Yael L. Maxwell

November 05, 2025

News Conference News TCT 2025

What Makes MedTech Great—or Not—and Envisioning Its Future

Caitlin E. Cox

November 04, 2025

News Conference News TCT 2025

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

Todd Neale

October 31, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

Presentation TCT 2025

Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

Presenter: John A. Spertus

October 27, 2025

Presentation TCT 2025

Placebo-Controlled Interventional Trials: A Sham No More

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation TCT 2025

Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

Presenter: John Gregson

October 27, 2025

Presentation TCT 2025

The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next?

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

Case-Based Discussion: Designing a Contemporary Cardiovascular Trial

Presenter: Stephan Windecker

October 27, 2025

Presentation TCT 2025

Enhancing Cardiovascular Device Clinical Trial Efficiency: Opportunities for Bayesian Predictive Modeling

Presenter: Ben Saville

October 27, 2025

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

Presentation TCT 2025

Economics and Reimbursements Pathways for Advanced and Novel Cardiovascular Interventions

Presenter: Jay S. Giri

October 26, 2025

Presentation TCT 2025

The Financial Landscape of the Cath Lab: Payment Pressures, Cost Management, and What’s Ahead

Presenter: Nirat Beohar

October 26, 2025

Presentation TCT 2025

PSA/MSA Models to Partner with Hospital Systems: The Devil is in the Details

Presenter: Partha Sardar

October 26, 2025

Presentation TCT 2025

Cardiologists in Hospital-Employed Models: Strategies for a Changing Landscape

Presenter: Herbert D. Aronow

October 26, 2025

Presentation TCT 2025

Cardiovascular Practice Models: Private vs. Hybrid — Playbook for 2025 and Beyond

Presenter: Tony Das

October 26, 2025

Presentation TCT 2025

OBL vs ASC: Choosing the Right Model for Cardiovascular and Vascular Procedures

Presenter: Samir B. Pancholy

October 26, 2025

News Conference News TCT 2025

Concerto in the Cath Lab: Music Benefits Heart Health After PCI

Michael O'Riordan

October 25, 2025

Advertisement

‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains

What Makes MedTech Great—or Not—and Envisioning Its Future

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Joint Modelling for Death and Quality of Life: Worthy as a Primary Endpoint

Placebo-Controlled Interventional Trials: A Sham No More

Spoiler Alert: Crossovers (Treatment Switches) can Negate the Trial Efficacy: Insights from The Ischemia Trial

The Core of Clinical Event Adjudication: Where is CEC Now and Where Do They Go Next?

Case-Based Discussion: Designing a Contemporary Cardiovascular Trial

Enhancing Cardiovascular Device Clinical Trial Efficiency: Opportunities for Bayesian Predictive Modeling

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Economics and Reimbursements Pathways for Advanced and Novel Cardiovascular Interventions

The Financial Landscape of the Cath Lab: Payment Pressures, Cost Management, and What’s Ahead

PSA/MSA Models to Partner with Hospital Systems: The Devil is in the Details

Cardiologists in Hospital-Employed Models: Strategies for a Changing Landscape

Cardiovascular Practice Models: Private vs. Hybrid — Playbook for 2025 and Beyond

OBL vs ASC: Choosing the Right Model for Cardiovascular and Vascular Procedures

Concerto in the Cath Lab: Music Benefits Heart Health After PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content